282 related articles for article (PubMed ID: 23052993)
1. [Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review].
Bader S; Weber M; Becker G
Schmerz; 2012 Sep; 26(5):568-86. PubMed ID: 23052993
[TBL] [Abstract][Full Text] [Related]
2. Laxatives or methylnaltrexone for the management of constipation in palliative care patients.
Candy B; Jones L; Goodman ML; Drake R; Tookman A
Cochrane Database Syst Rev; 2011 Jan; (1):CD003448. PubMed ID: 21249653
[TBL] [Abstract][Full Text] [Related]
3. Laxatives for the management of constipation in people receiving palliative care.
Candy B; Jones L; Larkin PJ; Vickerstaff V; Tookman A; Stone P
Cochrane Database Syst Rev; 2015 May; 2015(5):CD003448. PubMed ID: 25967924
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological prevention and treatment of opioid-induced constipation in cancer patients: A systematic review and meta-analysis.
Kistemaker KRJ; Sijani F; Brinkman DJ; de Graeff A; Burchell GL; Steegers MAH; van Zuylen L
Cancer Treat Rev; 2024 Apr; 125():102704. PubMed ID: 38452708
[TBL] [Abstract][Full Text] [Related]
5. Laxatives for the management of constipation in palliative care patients.
Miles CL; Fellowes D; Goodman ML; Wilkinson S
Cochrane Database Syst Rev; 2006 Oct; (4):CD003448. PubMed ID: 17054172
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological treatment of constipation in palliative care.
Clemens KE; Faust M; Jaspers B; Mikus G
Curr Opin Support Palliat Care; 2013 Jun; 7(2):183-91. PubMed ID: 23478431
[TBL] [Abstract][Full Text] [Related]
7. Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review).
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Evid Based Child Health; 2013 Jan; 8(1):57-109. PubMed ID: 23878124
[TBL] [Abstract][Full Text] [Related]
8. Systematic review with meta-analysis: efficacy and safety of treatments for opioid-induced constipation.
Vijayvargiya P; Camilleri M; Vijayvargiya P; Erwin P; Murad MH
Aliment Pharmacol Ther; 2020 Jul; 52(1):37-53. PubMed ID: 32462777
[TBL] [Abstract][Full Text] [Related]
9. Osmotic and stimulant laxatives for the management of childhood constipation.
Gordon M; Naidoo K; Akobeng AK; Thomas AG
Cochrane Database Syst Rev; 2012 Jul; (7):CD009118. PubMed ID: 22786523
[TBL] [Abstract][Full Text] [Related]
10. Management of constipation in patients receiving palliative care.
Cayley WE
Am Fam Physician; 2011 Dec; 84(11):1227-8. PubMed ID: 22150655
[No Abstract] [Full Text] [Related]
11. Use of methylnaltrexone for the treatment of opioid-induced constipation in critical care patients.
Sawh SB; Selvaraj IP; Danga A; Cotton AL; Moss J; Patel PB
Mayo Clin Proc; 2012 Mar; 87(3):255-9. PubMed ID: 22386181
[TBL] [Abstract][Full Text] [Related]
12. Methylnaltrexone: a subcutaneous treatment for opioid-induced constipation in palliative care patients.
Kyle G
Int J Palliat Nurs; 2009 Nov; 15(11):533-40. PubMed ID: 20081727
[TBL] [Abstract][Full Text] [Related]
13. Subsidised use of methylnaltrexone in Australia for palliative care.
Rowett DS; Clark K; Robinson MK; Currow DC
Med J Aust; 2012 Nov; 197(9):492. PubMed ID: 23121581
[No Abstract] [Full Text] [Related]
14. The role of opioid receptor antagonists in the treatment of opioid-induced constipation: a review.
Leppert W
Adv Ther; 2010 Oct; 27(10):714-30. PubMed ID: 20799006
[TBL] [Abstract][Full Text] [Related]
15. Methylnaltrexone: a novel approach for the management of opioid-induced constipation in patients with advanced illness.
Diego L; Atayee R; Helmons P; von Gunten CF
Expert Rev Gastroenterol Hepatol; 2009 Oct; 3(5):473-85. PubMed ID: 19817669
[TBL] [Abstract][Full Text] [Related]
16. Methylnaltrexone for opioid-induced constipation in advanced illness.
Thomas J; Karver S; Cooney GA; Chamberlain BH; Watt CK; Slatkin NE; Stambler N; Kremer AB; Israel RJ
N Engl J Med; 2008 May; 358(22):2332-43. PubMed ID: 18509120
[TBL] [Abstract][Full Text] [Related]
17. Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illness.
Chamberlain BH; Cross K; Winston JL; Thomas J; Wang W; Su C; Israel RJ
J Pain Symptom Manage; 2009 Nov; 38(5):683-90. PubMed ID: 19713070
[TBL] [Abstract][Full Text] [Related]
18. Management of opioid-induced constipation in cancer patients: focus on methylnaltrexone.
Gatti A; Sabato AF
Clin Drug Investig; 2012 May; 32(5):293-301. PubMed ID: 22413747
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of laxatives for chronic constipation in long-term care settings: A systematic review.
Alsalimy N; Madi L; Awaisu A
J Clin Pharm Ther; 2018 Oct; 43(5):595-605. PubMed ID: 29885259
[TBL] [Abstract][Full Text] [Related]
20. Methylnaltrexone for the treatment of opioid-induced constipation.
Bader S; Dürk T; Becker G
Expert Rev Gastroenterol Hepatol; 2013 Jan; 7(1):13-26. PubMed ID: 23265145
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
